Chemotherapieinduzierte Neuropathien
详细信息 查看全文
- 作者：Dr. W. Boehmerle (1) (2)
P. Huehnchen (1) (2)
M. Endres (1) (2) (3) (4)
1. Klinik und Hochschulambulanz f眉r Neurologie mit Lehrstuhl f眉r Experimentelle Neurologie ; Charit茅 鈥?Universit盲tsmedizin Berlin ; Charit茅platz 1 ; 10117 ; Berlin ; Deutschland
2. Cluster of Excellence NeuroCure ; Berlin ; Deutschland
3. Center for Stroke Research Berlin ; Charit茅 鈥?Universit盲tsmedizin Berlin ; Berlin ; Deutschland
4. German Center for Neurodegenerative Diseases (DZNE) ; Berlin ; Deutschland - 关键词：Chemotherapieinduzierte Neuropathie ; Neuropathischer Schmerz ; Axonal sensible Neuropathie ; Zytostatika ; Neurotoxizit盲t ; Chemotherapy ; induced neuropathy ; Neuropathic pain ; Sensory axonal neuropathy ; Cytostatic drugs ; Neurotoxicity
- 刊名：Der Nervenarzt
- 出版年：2015
- 出版时间：February 2015
- 年：2015
- 卷：86
- 期：2
- 页码：156-160
- 全文大小：321 KB
- 参考文献：1. Anderson H, Wagstaff J, Crowther D et al (1988) Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancer. Eur J Cancer Clin Oncol 24:1471鈥?479 CrossRef
2. Andre T, Boni C, Mounedji-Boudiaf L et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343鈥?351 CrossRef
3. Boehmerle W, Huehnchen P, Endres M (2014) Neurologische Nebenwirkungen von Zytostatika. Aktuel Neurol 41:21鈥?4 CrossRef
4. Cata JP, Weng HR, Burton AW et al (2007) Quantitative sensory findings in patients with bortezomib-induced pain. J Pain 8:296鈥?06 CrossRef
5. De Gramont A, Figer A, Seymour M et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938鈥?947
6. Durand JP, Deplanque G, Montheil V et al (2012) Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial. Ann Oncol 23:200鈥?05 CrossRef
7. Hershman DL, Lacchetti C, Dworkin RH et al (2014) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 32:1941鈥?967 CrossRef
8. Holland JF, Scharlau C, Gailani S et al (1973) Vincristine treatment of advanced cancer: a cooperative study of 392 cases. Cancer Res 33:1258鈥?264
9. Jones SE, Erban J, Overmoyer B et al (2005) Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. J Clin Oncol 23:5542鈥?551 CrossRef
10. Loprinzi CL, Reeves BN, Dakhil SR et al (2011) Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1. J Clin Oncol 29:1472鈥?478 CrossRef
11. Moreau P, Pylypenko H, Grosicki S et al (2011) Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study. Lancet Oncol 12:431鈥?40 CrossRef
12. Ogura M, Tobinai K, Hatake K et al (2014) Phase I/II study of brentuximab vedotin in Japanese patients with relapsed or refractory CD30-positive Hodgkin鈥檚 lymphoma or systemic anaplastic large-cell lymphoma. Cancer Sci 105:840鈥?46 CrossRef
13. Park SB, Goldstein D, Krishnan AV et al (2013) Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin 63:419鈥?37 CrossRef
14. Postma TJ, Vermorken JB, Liefting AJ et al (1995) Paclitaxel-induced neuropathy. Ann Oncol 6:489鈥?94
15. Richardson PG, Xie W, Mitsiades C et al (2009) Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy. J Clin Oncol 27:3518鈥?525 CrossRef
16. Roelofs RI, Hrushesky W, Rogin J et al (1984) Peripheral sensory neuropathy and cisplatin chemotherapy. Neurology 34:934鈥?38 CrossRef
17. Rosenberg B, Vancamp L, Krigas T (1965) Inhibition of cell division in escherichia coli by electrolysis products from a platinum electrode. Nature 205:698鈥?99 CrossRef
18. Smith EM, Pang H, Cirrincione C et al (2013) Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial. JAMA 309:1359鈥?367 CrossRef
19. Strumberg D, Brugge S, Korn MW et al (2002) Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer. Ann Oncol 13:229鈥?36 CrossRef
20. Van Der Hoop RG, Van Der Burg ME, Ten Bokkel Huinink WW et al (1990) Incidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatin. Cancer 66:1697鈥?702 CrossRef
21. Verstappen CC, Koeppen S, Heimans JJ et al (2005) Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening. Neurology 64:1076鈥?077 CrossRef
22. Wilson RH, Lehky T, Thomas RR et al (2002) Acute oxaliplatin-induced peripheral nerve hyperexcitability. J Clin Oncol 20:1767鈥?774 CrossRef
23. Younes A, Gopal AK, Smith SE et al (2012) Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin鈥檚 lymphoma. J Clin Oncol 30:2183鈥?189 CrossRef - 刊物主题：Medicine/Public Health, general; Neurology; Neurosurgery; Psychiatry; Psychotherapy;
- 出版者：Springer Berlin Heidelberg
- ISSN：1433-0407
文摘